Retail Trade
cocokara fine, Inc.
In the news
- No more backroom deals, Japanese M&A hunts for best offers Aug 17, 2019
- Japan drugstore chain Cocokara to pursue Matsumotokiyoshi merger Aug 14, 2019
- Japanese drugstore chains discuss merger to become top player Jun 2, 2019
- Japan drugstores log record Q1 profit Aug 10, 2017
- Market Scramble: Tokyo investors home in on market share Jun 8, 2017 See more articles on cocokara fine, Inc.
Business Summary
Cocokara Fine is a provider of healthcare services to drug store and pharmaceutical operation.
Financial Highlights
Mar 2021 | JPY | USD |
Revenue | 366,440M | 3,455.10M |
Gross Profit | 105,153M | 991.47M |
Operating income | 10,349M | 97.57M |
Income before tax | 7,480M | 70.52M |
Net income | 4,320M | 40.73M |
EBITDA | 14,886M | 140.35M |
Diluted EPS | 144.03 | 1.35 |
Dividends Per Share | 92 | 0.86 |
Total Assets | 203,407M | 1,840.78M |
Total liabilities | 61,896M | 560.14M |
Total equity | 141,508M | 1,280.61M |
Operating cash flow | 2,251M | 21.22M |
Currency in JPY | Currency in USD |
Historical Data
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
Revenue | 377,203M | 390,963M | 400,559M | 403,875M | 366,440M |
Gross Profit | 93,564M | 101,205M | 104,914M | 108,098M | 105,153M |
Operating income | 10,140M | 13,665M | 12,905M | 13,338M | 10,349M |
Income before tax | 11,339M | 14,638M | 13,795M | 12,971M | 7,480M |
Net income | 7,037M | 9,067M | 9,158M | 8,270M | 4,320M |
EBITDA | 14,162M | 17,641M | 16,870M | 17,863M | 14,886M |
Diluted EPS | 286.79 | 376.38 | 381.24 | 344.05 | 144.03 |
Dividends Per Share | 70 | 73 | 76 | 92 | 92 |
Total Assets | 146,963M | 158,177M | 172,727M | 208,298M | 203,407M |
Total liabilities | 63,723M | 70,365M | 77,644M | 68,642M | 61,896M |
Total equity | 83,237M | 87,810M | 95,081M | 139,653M | 141,508M |
Operating cash flow | 9,381M | 17,117M | 9,388M | 12,919M | 2,251M |
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
Revenue | 3,483.34M | 3,527.51M | 3,612.06M | 3,714.62M | 3,455.10M |
Gross Profit | 864.03M | 913.13M | 946.06M | 994.22M | 991.47M |
Operating income | 93.63M | 123.29M | 116.37M | 122.67M | 97.57M |
Income before tax | 104.71M | 132.07M | 124.39M | 119.30M | 70.52M |
Net income | 64.98M | 81.80M | 82.58M | 76.06M | 40.73M |
EBITDA | 130.78M | 159.16M | 152.12M | 164.29M | 140.35M |
Diluted EPS | 2.64 | 3.39 | 3.43 | 3.16 | 1.35 |
Dividends Per Share | 0.64 | 0.65 | 0.68 | 0.84 | 0.86 |
Total Assets | 1,318.88M | 1,487.32M | 1,560.52M | 1,929.48M | 1,840.78M |
Total liabilities | 571.86M | 661.63M | 701.48M | 635.83M | 560.14M |
Total equity | 746.98M | 825.66M | 859.02M | 1,293.62M | 1,280.61M |
Operating cash flow | 86.63M | 154.44M | 84.65M | 118.82M | 21.22M |
Valuation Measures
Mar 2021 | |
PER | 59.08 |
ROA | 2.09% |
ROE | 3.07% |
Operating margin | 2.82% |
Profit margin | 1.17% |
Key executives
- President & Representative Director: Atsushi Tsukamoto
- Manager-Finance: Hiroshi Sato
- Executive Officer & Manager-Information Technology: Yasuyuki Oike
- Senior Manager-Compliance & Manager-Legal Affairs: Masafumi Morita
- Director, VP & Head-Business Administration: Tsuyoshi Yamamoto
Shareholders
Contact Details
- Website:http://www.cocokarafine.co.jp
- Address: Innotech Building, 3-17-6 Shin-Yokohama, Yokohama, 222-0033, Japan
- Phone: +81.45.548.5929
Related Companies
- Medical Support YK
- Well Support YK
- E Well YK
- Cocokara Fine Board Incentive Plan
- CFIZ Co. Ltd.
- KikoMedical Corp.
- Miyabi Pharmacy Co., Ltd.
- Futatsuka Holdings KK
- Yakuho Shoji YK
- Flight YK
- Koishikawa Pharmacy KK
- K S YK
- Cocokara Fine Employee Incentive Plan
- Senior Cosmos Co., Ltd.
- Toho Chozai YK
- cocokarafine soleil Co. Ltd.
- Yamamoto Service KK
- Shanghai Cocokara Fine, Inc.
- Cocokara Fine Next Co., Ltd.
- cocokarafine associe, Inc.
- cocokara fine OEC, Inc.
- Cocokara fine Healthcare, Inc.
- I System KK (Yamaguchi)
- Kojido Corp.
- Kusuri No Ebina YK
- Finecare, Inc.
- Kodama Co., Ltd. (Niigata)
- Reha Works YK
- Medical Index YK
- Aianju KK
Competitors
- Welcia Holdings Co., Ltd.
- Medical System Network Co., Ltd.
- Sugi Holdings Co., Ltd.
- TSURUHA Holdings, Inc.
- Pharmarise Holdings Corp.
- COSMOS Pharmaceutical Corporation
- Sundrug Co., Ltd.
- MatsukiyoCocokara & Co.
- Nihon Chouzai Co., Ltd.
- Ain Holdings Inc.
- Qol Holdings Co., Ltd.
Copyright © 2022 FactSet Research Systems Inc. All rights reserved.
Last Updated on 1 Oct, 2021Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.